AGBL2 and rheumatoid arthritis: In previous studies, using cohorts in which many of the patients were recruited before the CCP tests became available, anti–CEP‐1 and/or anti‐cTNC5 positivity was higher in the anti‐CCP2–negative RA patients, increasing overall diagnostic sensitivity by ~5% 2, 3, 4.